The global biotech market is expected to reach USD 727.1 billion by 2025, according to a new report by Grand View Research, Inc. Fueled by the huge unmet market need, strong governmental support, overwhelming investment interest, and the continuous influx of returning professionals from Western countries, China’s biotech industry has developed rapidly in the past 5 years, tending to emerge as one of the new innovation center in the world. Through self-innovation and partnership, more and more Chinese biotech companies are getting active globally, through self-innovation and partnership, they are looking to gain a foothold in the world’s major markets.
The BFC Global Healthcare BD & Investment Conference is held every January at San Francisco. As one of the well-received satellite conferences during the week of JPM Healthcare conference, we will bring together front-runners of China’s biotech sector, senior management of international large Pharmas, and China’s leading institutional investors with the goal of providing exclusive industry insights and access to business opportunities for cross-border deals.
More than 1,000 entrepreneurs, investors and industry professionals are expected to come.The all-day event will cover the most hottest topics in the healthcare industry. There are company presentations from the top 50 most exciting Chinese biotech companies, panel discussions by industry experts, as well as roadshows and Q&A sections. At least 100 world-renowned VC/PE firms and over 100 leading multinational biotech companies from the U.S., Europe are expected to attend the landmark conference.
The conference will feature key topics in the following areas:
Last year, over 500 senior executives from more than 100 public and private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors attended the conference. More than 300 PE and VC investors from over 100 firms also attended the event. The conference provided an optimal environment for biotech companies to network with potential partners and professional service firms (accounting, law and investment bank), resulting in potential cross-border deals of $800M（in size）.